Search

Ana Lucrecia Woodward

Examiner (ID: 7465, Phone: (571)272-1082 , Office: P/1765 )

Most Active Art Unit
1765
Art Unit(s)
1796, 1501, 1711, 1765, 1512, 1314, 1504
Total Applications
3148
Issued Applications
2104
Pending Applications
173
Abandoned Applications
906

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6142098 [patent_doc_number] => 20110129440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/738521 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24036 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129440.pdf [firstpage_image] =>[orig_patent_app_number] => 12738521 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738521
Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof Oct 26, 2008 Abandoned
Array ( [id] => 5337993 [patent_doc_number] => 20090054457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'SUBSTITUTED HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/259085 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22882 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054457.pdf [firstpage_image] =>[orig_patent_app_number] => 12259085 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/259085
SUBSTITUTED HETEROCYCLIC COMPOUNDS Oct 26, 2008 Abandoned
Array ( [id] => 5576044 [patent_doc_number] => 20090143406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'New Phenylpiperazine' [patent_app_type] => utility [patent_app_number] => 12/258591 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5316 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143406.pdf [firstpage_image] =>[orig_patent_app_number] => 12258591 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/258591
Phenylpiperazine Oct 26, 2008 Issued
Array ( [id] => 6630928 [patent_doc_number] => 20100311749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => '4-BENZOYL-1-SUBSTITUTED-PIPERAZIN-2-ONE DERIVATIVES AS P2X7 MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/739462 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28243 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311749.pdf [firstpage_image] =>[orig_patent_app_number] => 12739462 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/739462
4-BENZOYL-1-SUBSTITUTED-PIPERAZIN-2-ONE DERIVATIVES AS P2X7 MODULATORS Oct 23, 2008 Abandoned
Array ( [id] => 5285524 [patent_doc_number] => 20090099199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/251627 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21691 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099199.pdf [firstpage_image] =>[orig_patent_app_number] => 12251627 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/251627
ORGANIC COMPOUNDS Oct 14, 2008 Abandoned
Array ( [id] => 217166 [patent_doc_number] => 07612076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Piperazinyl-pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 12/246523 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15998 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612076.pdf [firstpage_image] =>[orig_patent_app_number] => 12246523 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/246523
Piperazinyl-pyridine derivatives Oct 6, 2008 Issued
Array ( [id] => 4515027 [patent_doc_number] => 07910588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => '5-HT7 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/678345 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13293 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910588.pdf [firstpage_image] =>[orig_patent_app_number] => 12678345 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678345
5-HT7 receptor antagonists Sep 29, 2008 Issued
Array ( [id] => 5429131 [patent_doc_number] => 20090088441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Quinoline Compounds' [patent_app_type] => utility [patent_app_number] => 12/238982 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14801 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088441.pdf [firstpage_image] =>[orig_patent_app_number] => 12238982 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/238982
Quinoline Compounds Sep 25, 2008 Abandoned
Array ( [id] => 5509156 [patent_doc_number] => 20090082363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DEUTERIUM-ENRICHED POSACONAZOLE' [patent_app_type] => utility [patent_app_number] => 12/234229 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3993 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082363.pdf [firstpage_image] =>[orig_patent_app_number] => 12234229 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/234229
DEUTERIUM-ENRICHED POSACONAZOLE Sep 18, 2008 Abandoned
Array ( [id] => 4609463 [patent_doc_number] => 07994174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Pyridyl sulfonamides as modulators of ion channels' [patent_app_type] => utility [patent_app_number] => 12/212063 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20684 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994174.pdf [firstpage_image] =>[orig_patent_app_number] => 12212063 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/212063
Pyridyl sulfonamides as modulators of ion channels Sep 16, 2008 Issued
Array ( [id] => 4570378 [patent_doc_number] => 07858620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Cyanoisoquinoline' [patent_app_type] => utility [patent_app_number] => 12/208799 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11721 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858620.pdf [firstpage_image] =>[orig_patent_app_number] => 12208799 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/208799
Cyanoisoquinoline Sep 10, 2008 Issued
Array ( [id] => 5297173 [patent_doc_number] => 20090012099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Novel Compounds' [patent_app_type] => utility [patent_app_number] => 12/208543 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3922 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012099.pdf [firstpage_image] =>[orig_patent_app_number] => 12208543 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/208543
Novel Compounds Sep 10, 2008 Abandoned
Array ( [id] => 5272252 [patent_doc_number] => 20090076028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ITRACONAZOLE' [patent_app_type] => utility [patent_app_number] => 12/207861 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076028.pdf [firstpage_image] =>[orig_patent_app_number] => 12207861 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/207861
DEUTERIUM-ENRICHED ITRACONAZOLE Sep 9, 2008 Abandoned
Array ( [id] => 5361888 [patent_doc_number] => 20090036682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Quinoline Derivatives and Their Use as 5-HT6 Ligands' [patent_app_type] => utility [patent_app_number] => 12/205079 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15620 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036682.pdf [firstpage_image] =>[orig_patent_app_number] => 12205079 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/205079
Quinoline derivatives and their use as 5-HT6 ligands Sep 4, 2008 Issued
Array ( [id] => 4548471 [patent_doc_number] => 07960385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Guanidine-containing compounds useful as muscarinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/231861 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26681 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960385.pdf [firstpage_image] =>[orig_patent_app_number] => 12231861 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/231861
Guanidine-containing compounds useful as muscarinic receptor antagonists Sep 4, 2008 Issued
Array ( [id] => 5436282 [patent_doc_number] => 20090170869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/203946 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25484 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170869.pdf [firstpage_image] =>[orig_patent_app_number] => 12203946 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/203946
PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR Sep 3, 2008 Abandoned
Array ( [id] => 6537586 [patent_doc_number] => 20100204242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Piperazine Derivative Having Affinity for the Histamine H3 Receptor' [patent_app_type] => utility [patent_app_number] => 12/676158 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25480 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204242.pdf [firstpage_image] =>[orig_patent_app_number] => 12676158 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/676158
Piperazine derivative having affinity for the histamine H3 receptor Sep 3, 2008 Issued
Array ( [id] => 53280 [patent_doc_number] => 07772226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Condensed imidazole derivatives' [patent_app_type] => utility [patent_app_number] => 12/199982 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90953 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772226.pdf [firstpage_image] =>[orig_patent_app_number] => 12199982 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/199982
Condensed imidazole derivatives Aug 27, 2008 Issued
Array ( [id] => 5272251 [patent_doc_number] => 20090076027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED LURASIDONE' [patent_app_type] => utility [patent_app_number] => 12/196722 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3963 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076027.pdf [firstpage_image] =>[orig_patent_app_number] => 12196722 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196722
DEUTERIUM-ENRICHED LURASIDONE Aug 21, 2008 Abandoned
Array ( [id] => 4648 [patent_doc_number] => 07812021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Pyrrolidine aryl-ether as NK3 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/195545 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16607 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812021.pdf [firstpage_image] =>[orig_patent_app_number] => 12195545 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195545
Pyrrolidine aryl-ether as NK3 receptor antagonists Aug 20, 2008 Issued
Menu